SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-219590
Filing Date
2011-08-11
Accepted
2011-08-11 16:02:08
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 455875
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 9609
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9869
4 CERTIFICATION OF CEO AND CFO PURSUANT TO RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4834
10 GRAPHIC g201809g08h77.jpg GRAPHIC 9027
  Complete submission text file 0001193125-11-219590.txt   1634655

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20110630.xml EX-101.INS 201908
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20110630.xsd EX-101.SCH 10524
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20110630_cal.xml EX-101.CAL 26766
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20110630_lab.xml EX-101.LAB 86362
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20110630_pre.xml EX-101.PRE 54895
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 111027784
SIC: 2834 Pharmaceutical Preparations